NCT03862131View on ClinicalTrials.gov

PROactive Evaluation of Function to Avoid CardioToxicity

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 13, 2019

Primary Completion Date

June 14, 2024

Study Completion Date

June 14, 2024

Conditions
CardiotoxicityBreast CancerLymphomaSarcomaLeukemiaMyelomaLung Cancer
Interventions
DEVICE

MyoStrain®

MyoStrain® SENC software receives image data from MRI storage archives and performs viewing, image manipulation, communication, printing, and quantification of images.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Myocardial Solutions
All Listed Sponsors
collaborator

Myocardial Solutions

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT03862131 - PROactive Evaluation of Function to Avoid CardioToxicity | Biotech Hunter | Biotech Hunter